Questions Remain Over Synlait's Advanced Nutrition -- Market Talk

Dow Jones
2025/03/10

2323 GMT - Synlait Milk's turnaround has been quicker than Bell Potter analyst Jonathan Snape anticipated, but question marks remain over the future of the dairy producer's advanced nutrition business. Snape tells clients that the pace of the turnaround has been reflected by a rally in Synlait's shares. He calls out the improvement in Synlait's ingredients business, continued cost control, and new business development within advanced nutrition. However, he warns that the latter could take a hit if a2 Milk, which had an exclusivity agreement with Synlait until January 2025, vertically integrates into supply chain assets. Bell Potter raises its target price to A$0.90 from A$0.425, and maintains a hold rating. Shares are up 2.5% at A$0.83. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

March 09, 2025 19:23 ET (23:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10